GR3015812T3 - Anti-inflammatory analgesic patch. - Google Patents

Anti-inflammatory analgesic patch.

Info

Publication number: GR3015812T3
Authority: GR; Greece
Prior art keywords: reserver; drug; inflammatory analgesic; analgesic patch; acid
Prior art date: 1989-12-25

Application number

GR950400942T

Other languages

English (en)

Inventor

Akihito Oji

Yukihiro Tada

Noriyuki Sasaki

Mitsuo Mizumura

Original Assignee

Lederle Japan Ltd

Teikoku Seiyaku Kk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-25

Filing date

1995-04-17

Publication date

1995-07-31

1995-04-17 Application filed by Lederle Japan Ltd, Teikoku Seiyaku Kk filed Critical Lederle Japan Ltd

1995-07-31 Publication of GR3015812T3 publication Critical patent/GR3015812T3/el

Links

230000000202 analgesic effect Effects 0.000 title abstract 2
230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
229940079593 drug Drugs 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 abstract 1
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 abstract 1
239000002671 adjuvant Substances 0.000 abstract 1
150000001412 amines Chemical class 0.000 abstract 1
QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
229920001577 copolymer Polymers 0.000 abstract 1
DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 abstract 1
229960003338 crotamiton Drugs 0.000 abstract 1
229960000192 felbinac Drugs 0.000 abstract 1
239000003906 humectant Substances 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
150000007524 organic acids Chemical class 0.000 abstract 1
239000002562 thickening agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pain & Pain Management (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

GR950400942T 1989-12-25 1995-04-17 Anti-inflammatory analgesic patch. GR3015812T3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP1332599A JP2839164B2 (ja)	1989-12-25	1989-12-25	消炎鎮痛貼付剤

Publications (1)

Publication Number	Publication Date
GR3015812T3 true GR3015812T3 (en)	1995-07-31

Family

ID=18256747

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR950400942T GR3015812T3 (en)	1989-12-25	1995-04-17	Anti-inflammatory analgesic patch.

Country Status (10)

Country	Link
US (1)	US5116621A (el)
EP (1)	EP0436217B1 (el)
JP (1)	JP2839164B2 (el)
KR (1)	KR0180007B1 (el)
AT (1)	ATE120648T1 (el)
CA (1)	CA2033122C (el)
DE (1)	DE69018424T2 (el)
DK (1)	DK0436217T3 (el)
ES (1)	ES2070261T3 (el)
GR (1)	GR3015812T3 (el)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5462744A (en) *	1989-12-01	1995-10-31	Boehringer Ingelheim Kg	Transdermal system for the administration of pharmacological compounds under pH-controlled conditions
US5902600A (en) *	1992-12-21	1999-05-11	Healthpoint, Ltd.	Hydrogel polymer wound dressing
AU667161B2 (en) *	1993-04-28	1996-03-07	Daiichi Pharmaceutical Co., Ltd.	Butyrophenone transdermal compositions
US5409691A (en) *	1993-10-18	1995-04-25	Swain; Dan E.	Solution comprising aluminum acetate and glycerin
WO1995028914A1 (en) *	1994-04-21	1995-11-02	Hisamitsu Pharmaceutical Co., Inc.	Percutaneously administrable base composition and percutaneously administrable drug composition prepared therefrom
JPH10120560A (ja) *	1996-08-26	1998-05-12	Sankyo Co Ltd	ロキソプロフェン含有外用製剤
US5800832A (en) *	1996-10-18	1998-09-01	Virotex Corporation	Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
JPH10265374A (ja) *	1997-03-24	1998-10-06	Saitama Daiichi Seiyaku Kk	外用剤組成物及びその製造方法
US20050048102A1 (en) *	1997-10-16	2005-03-03	Virotex Corporation	Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
US6211296B1 (en)	1998-11-05	2001-04-03	The B. F. Goodrich Company	Hydrogels containing substances
JP4584381B2 (ja) *	1999-07-30	2010-11-17	久光製薬株式会社	フェルビナク含有貼付剤
US6698162B2 (en)	2000-03-23	2004-03-02	Teikoku Pharma Usa, Inc.	Methods of producing a terminally sterilized topical patch preparation
JP4648518B2 (ja)	2000-06-01	2011-03-09	帝國製薬株式会社	４−ビフェニル酢酸含有貼付剤
US20030216758A1 (en) *	2001-12-28	2003-11-20	Angiotech Pharmaceuticals, Inc.	Coated surgical patches
TWI412570B (zh) *	2004-04-27	2013-10-21	Showa Denko Kk	Adhesive for patch and method for producing the same
TWI414320B (zh) *	2004-05-13	2013-11-11	久光製藥股份有限公司	含有非類固醇系消炎鎮痛劑之外用經皮製劑
DK2054031T3 (en)	2006-07-21	2016-05-17	Biodelivery Sciences Int Inc	Transmucosal delivery devices with improved uptake
KR100867262B1 (ko)	2007-01-17	2008-11-06	대화제약 주식회사	펠비낙을 함유하는 플라스터 조성물
US20110319399A1 (en) *	2009-03-11	2011-12-29	Kowa Co., Ltd.	External preparation containing analgesic/anti-inflammatory agent
US9549842B2 (en)	2011-02-04	2017-01-24	Joseph E. Kovarik	Buccal bioadhesive strip and method of treating snoring and sleep apnea
US8701671B2 (en)	2011-02-04	2014-04-22	Joseph E. Kovarik	Non-surgical method and system for reducing snoring
US11951139B2 (en)	2015-11-30	2024-04-09	Seed Health, Inc.	Method and system for reducing the likelihood of osteoporosis
US11844720B2 (en)	2011-02-04	2023-12-19	Seed Health, Inc.	Method and system to reduce the likelihood of dental caries and halitosis
US11998479B2 (en)	2011-02-04	2024-06-04	Seed Health, Inc.	Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11951140B2 (en)	2011-02-04	2024-04-09	Seed Health, Inc.	Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US12279989B2 (en)	2011-02-04	2025-04-22	Seed Health, Inc.	Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US12257272B2 (en)	2015-12-24	2025-03-25	Seed Health, Inc.	Method and system for reducing the likelihood of developing depression in an individual
US12533312B2 (en)	2011-02-04	2026-01-27	Seed Health, Inc.	Method and system for preventing sore throat in humans
AU2012296346A1 (en)	2011-08-18	2014-04-03	Biodelivery Sciences International, Inc.	Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US9901539B2 (en)	2011-12-21	2018-02-27	Biodelivery Sciences International, Inc.	Transmucosal drug delivery devices for use in chronic pain relief
JP2012144562A (ja) *	2012-04-17	2012-08-02	Teikoku Seiyaku Co Ltd	貼付剤
JP5949285B2 (ja) *	2012-07-31	2016-07-06	ライオン株式会社	貼付剤
CN105209084B (zh)	2013-03-13	2018-07-03	艾利丹尼森公司	改善的粘合性能
US12005085B2 (en)	2013-12-20	2024-06-11	Seed Health, Inc.	Probiotic method and composition for maintaining a healthy vaginal microbiome
US11969445B2 (en)	2013-12-20	2024-04-30	Seed Health, Inc.	Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11980643B2 (en)	2013-12-20	2024-05-14	Seed Health, Inc.	Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US12329783B2 (en)	2013-12-20	2025-06-17	Seed Health, Inc.	Method and system to improve the health of a person's skin microbiome
US12246043B2 (en)	2013-12-20	2025-03-11	Seed Health, Inc.	Topical application to treat acne vulgaris
US11998574B2 (en)	2013-12-20	2024-06-04	Seed Health, Inc.	Method and system for modulating an individual's skin microbiome
US11833177B2 (en)	2013-12-20	2023-12-05	Seed Health, Inc.	Probiotic to enhance an individual's skin microbiome
US11826388B2 (en)	2013-12-20	2023-11-28	Seed Health, Inc.	Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11839632B2 (en)	2013-12-20	2023-12-12	Seed Health, Inc.	Topical application of CRISPR-modified bacteria to treat acne vulgaris
JP7219623B2 (ja) *	2018-01-30	2023-02-08	日東電工株式会社	経皮吸収型製剤
US20240115528A1 (en) *	2021-01-29	2024-04-11	Kao Corporation	Composition for external application
CN116723865A (zh) *	2021-01-29	2023-09-08	花王株式会社	外用剂组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5842168B2 (ja) *	1974-12-20	1983-09-17	トウコウヤクヒンコウギヨウカブシキガイシヤ	局所用剤の製造方法
JPS59222409A (ja) *	1983-06-01	1984-12-14	Nippon Redarii Kk	消炎鎮痛ゲル軟膏剤
JPS60188315A (ja) *	1984-03-07	1985-09-25	Yamanouchi Pharmaceut Co Ltd	グリチルレチン酸配合鎮痒プラスター
JPS60209515A (ja) *	1984-04-03	1985-10-22	Hokuriku Seiyaku Co Ltd	消炎鎮痛クリ−ム剤
US4954343A (en) *	1986-03-29	1990-09-04	Nitto Electric Industrial Co., Ltd.	Dermal pharmaceutical preparations
AU607172B2 (en) *	1986-12-22	1991-02-28	Cygnus, Inc.	Diffusion matrix for transdermal drug administration
JPH0696529B2 (ja) *	1987-03-31	1994-11-30	積水化学工業株式会社	ニトログリセリン貼付剤およびその製造方法
EP0303445A1 (en) *	1987-08-13	1989-02-15	Walton S.A.	Clebopride transdermal patch
GB2217595B (en) *	1988-04-21	1991-11-20	American Cyanamid Co	Antiinflammatory gel

1989
- 1989-12-25 JP JP1332599A patent/JP2839164B2/ja not_active Expired - Fee Related
1990
- 1990-12-24 KR KR1019900021645A patent/KR0180007B1/ko not_active Expired - Lifetime
- 1990-12-24 US US07/633,146 patent/US5116621A/en not_active Expired - Lifetime
- 1990-12-24 CA CA002033122A patent/CA2033122C/en not_active Expired - Lifetime
- 1990-12-27 ES ES90125524T patent/ES2070261T3/es not_active Expired - Lifetime
- 1990-12-27 DK DK90125524.0T patent/DK0436217T3/da active
- 1990-12-27 EP EP90125524A patent/EP0436217B1/en not_active Expired - Lifetime
- 1990-12-27 DE DE69018424T patent/DE69018424T2/de not_active Expired - Lifetime
- 1990-12-27 AT AT90125524T patent/ATE120648T1/de not_active IP Right Cessation
1995
- 1995-04-17 GR GR950400942T patent/GR3015812T3/el unknown

Also Published As

Publication number	Publication date
CA2033122C (en)	2003-08-19
ES2070261T3 (es)	1995-06-01
ATE120648T1 (de)	1995-04-15
JPH03193728A (ja)	1991-08-23
DK0436217T3 (da)	1995-05-01
DE69018424T2 (de)	1995-09-21
EP0436217A2 (en)	1991-07-10
DE69018424D1 (de)	1995-05-11
EP0436217A3 (en)	1991-09-25
EP0436217B1 (en)	1995-04-05
US5116621A (en)	1992-05-26
JP2839164B2 (ja)	1998-12-16
CA2033122A1 (en)	1991-06-26
KR910011248A (ko)	1991-08-07
KR0180007B1 (ko)	1999-03-20

Publication	Publication Date	Title
EP0436217A3 (en)	1991-09-25	Anti-inflammatory analgesic patch
MX9206577A (es)	1993-05-01	COMPOSICIóN FARMACEUTICA PARA INHIBIR EL CRECIMIENTO DE CELULAS TUMORALES
GEP20032965B (en)	2003-05-12	Pharmaceutical Compound
ATE149349T1 (de)	1997-03-15	Einarbeitung eines poly-n-vinylamids in ein transdermales system
ATE361093T1 (de)	2007-05-15	Selektiv auf die leber wirkende pharmazeutisch aktive substanz
MY102378A (en)	1992-06-17	Transdermal delivery system.
ES2124320T3 (es)	1999-02-01	Desinfectante de yodo y resina y un procedimiento para su preparacion.
CA2158475A1 (en)	1994-09-29	Composition and method for reducing toxicity of biologically-active factors
ATE113839T1 (de)	1994-11-15	Arzneimittel gegen impotenz.
CA2251966A1 (en)	1997-10-30	Transdermally administered dextromethorphan as antitussive agent
GEP20002332B (en)	2000-12-25	Cefalosporin Derivatives
CA2202531A1 (en)	1996-04-25	Lyophilizate of lipid complex of water insoluble camptothecins
BG47648A3 (en)	1990-08-15	Method for preparing of triazolyl quanolinic compounds
EP0328924A3 (en)	1991-03-20	Thienotriazolodiazepine compounds and pharmaceutical uses thereof
ES8606339A1 (es)	1986-04-01	Procedimiento para la produccion de indolofenantridinas
EP0565146A3 (en)	1993-10-27	Use of a thioester for preparing pharmaceutical compositions for the treatment of ischemia and reperfusion syndromes
EP0365956A3 (en)	1991-08-21	Carcinostatic agents
EP0353474A3 (en)	1991-03-27	Glycerin derivative and its pharmacological use
MY132436A (en)	2007-10-31	Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
CA2103707A1 (en)	1992-08-22	Treatment of non-small cell lung carcinoma
EP0345883A3 (en)	1991-09-25	Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine
CA2090234A1 (en)	1992-03-12	Method for providing improved analgesic effect
SU1744810A1 (ru)	1994-05-30	Вазоактивное средство, нормализующее функции вегетативной нервной системы "димефосфон"
CA2103708A1 (en)	1992-08-22	Treatment of ovarian cancer
ATE102934T1 (de)	1994-04-15	Fluorierte flavon-essigsaeure.